Addwize OD 18mg Tablet

Free Shipping on minimum Orders of ₹1000

                    0
0

                    Home
Medicine
OTC
								Nutritional Drinks
											Kids Nutrition (2-15 Yrs)
Baby & Infant Food
Protein Drinks
Ensure

Healthcare Devices
											Diabetes Monitoring
Dr Morepen

Ayurveda
											Diabetes Care
Ayurveda Personal Care

Sexual Wellness
											Sexual Health Supplements

Skin Care
											Acne Care

Homeopathy
											BJAIN Homeopathy

Wheelchairs & Walkers
Surgical Equipement 
Mens Care
Women Care
Baby Care
Cosmetic

Addwize OD 18mg Tablet is a medicine used in the treatment of attention deficit hyperactivity disorder (a behavioral disorder in children marked by poor concentration, hyperactivity, and learning difficulties). It helps to improve attention span, concentration and reduces impulsive behavior. Addwize OD 18mg Tablet may be taken with or without food. It is advised to take this medicine at a fixed time each day to maintain a consistent level in the blood. If you miss any doses, take it as soon as you remember. Do not skip any doses and finish the full course of treatment even if you feel better. This medication mustn't be stopped suddenly as it may worsen your symptoms.Some common side effects of this medicine include headache, insomnia (difficulty sleeping), abdominal pain, and nervousness. However, these side effects are temporary and usually resolve on their own in some time. Please consult your doctor if these do not subside or bother you. This medicine causes dizziness and sleepiness, so do not drive or do anything that requires mental focus until you know how this medicine affects you.Before taking Addwize OD 18mg Tablet, inform your doctor if you have any problems with your kidneys, heart, liver, or have a history of seizures (epilepsy or fits). Inform your doctor if you develop any unusual changes in mood or behavior, new or worsening depression, or if you have any suicidal thoughts.

MRP: ₹230.63

Inclusive of all taxes

Product Details
Manufacturers	Sun Pharmaceutical Industries Ltd
Salt Composition	Methylphenidate (18mg)
Medicine Type	drugs
Packinging	strip of 10 tablets
Package	Strip
Quantity	10
Product Form	Tablet
Prescription Required	Prescription Required
Fact Box	Chemical Class :: Aralkylamines\|Habit Forming :: Yes\|Therapeutic Class :: NEURO CNS\|Action Class :: Centrally Acting Sympathomimetics
Primary use	Attention deficit hyperactivity disorder (ADHD)
Storage	Store below 30?C
Common Side Effect	Headache \| Insomnia (difficulty in sleeping) \| Abdominal pain \| Nervousness
Alcohol Interaction	UNSAFE
Pregnancy Interaction	SAFE IF PRESCRIBED
Lactation Interaction	CONSULT YOUR DOCTOR
Driving Interaction	UNSAFE
Kidney Interaction	CONSULT YOUR DOCTOR
Liver Interaction	CONSULT YOUR DOCTOR
Manufacturer Address	Sun Pharmaceutical Industries Ltd \| Plot no 107/108,Namli block , Ranipool, East Sikkim 737135 \|\| Khasra No. 1335-1340,Near EPIP- I, Vill - Bhatoli Kalan ,Baddi, Solan, Himachal Pradesh, 173205
Country of Origin	India

Benefits
How to use
Safety Advise
If Miss
Q_A
How It Works
Drug-Drug Interaction
Review

- Alcohol : UNSAFE

Do not drink alcohol while you are taking this medicine. Addwize OD 18mg Tablet may cause excessive drowsiness when taken with alcohol. | - Pregnancy : SAFE IF PRESCRIBED

Addwize OD 18mg Tablet is generally considered safe to use during pregnancy. Animal studies do not indicate harmful effects. However, there are limited human studies. | - Breast feeding : CONSULT YOUR DOCTOR

Addwize OD 18mg Tablet may be unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. It should be used only if the expected benefit outweighs the potential risk. Please consult your doctor. | - Driving : UNSAFE

Addwize OD 18mg Tablet may decrease alertness, affect your vision, or make you feel sleepy and dizzy. Do not drive if these symptoms occur.You may feel dizzy, have problems focussing or have blurred vision when taking Addwize OD 18mg Tablet. This may affect your driving ability. | - Kidney : CONSULT YOUR DOCTOR

There is limited data available on the use of Addwize OD 18mg Tablet in patients with kidney disease. Please consult your doctor.Caution should be exercised in patients with underlying kidney disease. | - Liver : CONSULT YOUR DOCTOR

There is limited data available on the use of Addwize OD 18mg Tablet in patients with liver disease.

Is Addwize OD 18mg Tablet a monoamine oxidase inhibitor/ opiate/ amphetamine?::: Addwize OD 18mg Tablet is central nervous system stimulant drug that is used in attention deficit hyperactivity disorder (a behavioral disorder in children marked by poor concentration, hyperactivity, and learning difficulties). It is not monoamine oxidase inhibitor or an opiate. It is similar in function to amphetamine, but milder in nature| Does Addwize OD 18mg Tablet keep you awake or help you focus?::: Yes, Addwize OD 18mg Tablet increases wakefulness, vigilance and attention span| Does Addwize OD 18mg Tablet make you high?::: Addwize OD 18mg Tablet has the ability to alter mood and feelings such that the effects are perceived by some as pleasant or ?high'. Addwize OD 18mg Tablet belongs to a sub schedule X consisting psychotropic and habit forming substances. It is available strictly as per the prescription and should always be used as advised by doctor| Does Addwize OD 18mg Tablet expire/ go bad?::: Like all other medicines, Addwize OD 18mg Tablet expires.The expiry date is mentioned on the pill-box or strip. Addwize OD 18mg Tablet should not be used beyond this date of expiry.

-Tranylcypromine (Oral Route): Life-threatening

Do not consume Tranylcypromine with Methylphenidate. If Tranylcypromine is essential, ensure a gap of At least 2 weeks between taking Tranylcypromine and Methylphenidate. Please consult your doctor.

| -Moclobemide (Oral Route): Life-threatening

Concurrent use may cause a severe or fatal increase in blood pressure. Do not consume Moclobemide with Methylphenidate. If Moclobemide is essential, ensure a gap of at least 2 weeks after discontinuing Methylphenidate. Please consult your doctor.

| -Selegiline (Oral Route): Life-threatening

Do not consume Selegiline with Methylphenidate. If Selegiline is essential, ensure a gap of at least 2 weeks after discontinuing Methylphenidate. Please consult your doctor.

| -Linezolid (Oral Route): Severe

Do not consume Methylphenidate during treatment with and for up to 14 days after stopping Linezolid. Concurrent use may increase the risk of high blood pressure.

| -Linezolid (Injection Route): Severe

Do not consume Methylphenidate during treatment with and for up to 14 days after stopping Linezolid. Concurrent use may increase the risk of high blood pressure.